Print Friendly, PDF & Email

NCT/Study#

NCT02964013 /

MK-7684-001

A Phase 1 Trial Of MK-7684 As Monotherapy And In Combination With Pembrolizumab In Subjects With Advanced Solid Tumors

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: